Skip to content

Drug interactions

Brentuximab vedotin + Rifampicin

Severity: Moderate

Brentuximab vedotin and Rifampicin: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Rifampicin lowers exposure to MMAE, the cytotoxic component released from brentuximab vedotin. This may reduce antitumor efficacy.

What this interaction means in plain words

Brentuximab vedotin and Rifampicin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Brentuximab vedotin belongs to Oncology; Rifampicin belongs to Anti Bacterial.

Evidence level: High

Why it happens

Rifampicin induces CYP3A4, increasing MMAE metabolism.

What to do

Where possible, choose an alternative to rifampicin. If it must be used, monitor for reduced tumor response.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Brentuximab vedotin and Rifampicin, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Brentuximab vedotin with Rifampicin?

MediHelp rates the interaction as moderate. Brentuximab vedotin and Rifampicin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Rifampicin lowers exposure to MMAE, the cytotoxic component released from brentuximab vedotin. This may reduce antitumor efficacy.

How serious is the interaction between Brentuximab vedotin and Rifampicin?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Where possible, choose an alternative to rifampicin. If it must be used, monitor for reduced tumor response.

What other medicines interact with Brentuximab vedotin?

MediHelp also lists interactions of Brentuximab vedotin with, for example, Bleomycin, Siponimod, Apalutamide. The full list is on the Brentuximab vedotin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in